R1 RCM Holdco Inc
F:6HL0
R1 RCM Holdco Inc
Cost of Revenue
R1 RCM Holdco Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R1 RCM Holdco Inc
F:6HL0
|
Cost of Revenue
-$1.8B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-25%
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$307.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-11%
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$180.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
See Also
What is R1 RCM Holdco Inc's Cost of Revenue?
Cost of Revenue
-1.8B
USD
Based on the financial report for Dec 31, 2023, R1 RCM Holdco Inc's Cost of Revenue amounts to -1.8B USD.
What is R1 RCM Holdco Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-25%
Over the last year, the Cost of Revenue growth was -22%. The average annual Cost of Revenue growth rates for R1 RCM Holdco Inc have been -20% over the past three years , -18% over the past five years , and -25% over the past ten years .